Page last updated: 2024-08-21

malondialdehyde and olaparib

malondialdehyde has been researched along with olaparib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahmad, A; Herndon, DN; Olah, G; Szabo, C	1

Other Studies

1 other study(ies) available for malondialdehyde and olaparib

Article	Year
The clinically used PARP inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third-degree burn injury. British journal of pharmacology, 2018, Volume: 175, Issue:2 Topics: Animals; Burns; Disease Models, Animal; Inflammation; Inflammation Mediators; Lung; Male; Malondialdehyde; Mice; Myocardium; Peroxidase; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Troponin T; Wound Healing	2018

Article

Year

The clinically used PARP inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third-degree burn injury.

British journal of pharmacology, 2018, Volume: 175, Issue:2

Topics: Animals; Burns; Disease Models, Animal; Inflammation; Inflammation Mediators; Lung; Male; Malondialdehyde; Mice; Myocardium; Peroxidase; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Troponin T; Wound Healing

2018